Enhancing Drug Development with Tox Vision Plus Plus
In the field of biopharmaceutical research, the ability to connect the dots and gain better insight is invaluable. As a non-clinical scientist or regulatory reviewer, you understand the importance of analyzing patterns within non-clinical research data and comparing them against other studies to quickly identify potential safety issues. This is where PointCross Life Sciences’ Tox Vision Plus Plus comes in as the ideal solution for your drug development program.
Tox Vision Plus Plus builds upon the success of its predecessor, the original Tox Vision Viewer, which was developed in collaboration with regulatory reviewers and biopharma scientists. Gone are the days of manual study consolidation and time-consuming review methods that lacked standardization. With Tox Vision Plus Plus, pharma R&D scientists finally have access to a streamlined process for visualizing, comparing, and evaluating non-clinical data across multiple studies within a single viewing environment.
One of the key features of Tox Vision Plus Plus is its integration with PointCross’s Non-Clinical Study Data Repository (NSDR), which utilizes an extended version of the SEND standard. This enables rich visualization, seamless import and export of the entire non-clinical study data set, eliminating the limitations imposed by the current SEND standard. As an extension of your scientific and review toolset, Tox Vision Plus Plus empowers you to observe, detect, and discover elusive or weak patterns throughout the complete life cycle of studies.
Moreover, Tox Vision Plus Plus facilitates easy data analysis by allowing you to export data views into widely-used tools like Microsoft Excel. This further empowers you to delve deeper into your research findings and extract valuable insights. When combined with PointCross’s Study Data Integration and Search (SDIS) system and the nSDRG, you gain the ability to swiftly search and uncover safety trends and weak signals across thousands of studies within seconds.
One of the notable advantages of Tox Vision Plus Plus is its real-time capabilities, which enable the timely detection of critical areas in your drug development program that may require further exploration. By visualizing current study data and comparing it against multiple studies, you can make informed decisions regarding safety and potential toxicity issues before regulators do.
If you are a dedicated researcher striving for better safety decision-making and aiming to stay ahead of regulatory requirements, Tox Vision Plus Plus is the solution you’ve been waiting for. Contact PointCross Life Sciences today to learn more about how Tox Vision Plus Plus can revolutionize your drug development program. Gain the power to connect the dots, uncover insights, and shape the future of biopharmaceutical research.